• Event Type: In-person group Analyst/Institutional Investors' Meet
  • Date and Time: October 27, 2026 (specific time not mentioned in the disclosure)
  • Location: Mumbai
  • Purpose: The meeting will feature the company's senior management along with members of the leadership team of Armed Cell Therapeutics (ACTx)
  • Management Participants: Senior management of Mankind Pharma and leadership team of Armed Cell Therapeutics (ACTx) - specific names and designations not provided
  • Regulatory Compliance: The intimation is made pursuant to Regulation 30 & 51 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • Virtual Access: A Zoom link is indicated as "Click here" in the schedule table

Additional Notes Section

  • Website Availability: The information is available on the company website at www.mankindpharma.com
  • Investor Relations Contacts:
  • Mankind Pharma: Archit Gupta (investor.relations@mankindpharma.com, +91 97900 90279)
  • Adfactors PR: Smit Shah (smit.shah@adfactorspr.com, +91 98707 89596) and Forum Goshar (forum.goshar@adfactorspr.com, +91 70456 46599)
  • Disclaimer: The schedule is subject to change due to exigencies
  • No Financial Data: The announcement contains no financial data, results, or guidance figures
  • Attachments: No attachments or presentations were mentioned in this specific disclosure